Melanocyte-Stimulating Hormone and Persistent Tardive Dyskinesia: A Hypothesis

References

• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Barnea A., Cho G., Porter J. C. Disproportionate accumulation of immunoreactive corticotropin, melanotropin and lipotropin in the brain of the maturing rat. Endocrinology 1981; 109: 1990–1998
   PubMed Web of Science ®Google Scholar
• Barnes T. R. E., Braude W. M. Persistent akathisia associated with early tardive dyskinesia. Postgraduate Medical Journal 1984; 60: 359–361
   PubMed Web of Science ®Google Scholar
• Bertolini A., Vergoni A. V., Poggioli R., Gessa G. L. Morphine and beta-endorphin antagonize posture and locomotor disorders induced by the injection of ACTH 1–24 in the rat locus coeruleus. Life Sciences 1986; 38: 373–377
   PubMed Web of Science ®Google Scholar
• Blum I., Munitz H., Shalev A., Roberts E. Naloxone may be beneficial in the treatment of tardive dyskinesia. Clinical Neuropharmacology 1984; 7: 265–267
   PubMed Web of Science ®Google Scholar
• Blum I., Nisipeannu P. F., Roberts E. Naloxone in tardive dyskinesia. Psychopharmacology 1987; 93: 538
   PubMed Web of Science ®Google Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Carter R. J., Shuster S. Melanocyte-stimulating hormone-mimetic action of phenothiazines. Journal of Pharmacology and Pharmacy 1977; 30: 233–235
   Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971; 172: 450–452
   Google Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience & Biobehavioral Reviews 1978; 4: 451–458
   Web of Science ®Google Scholar
• Dunn A. J., Iuvone P. M., Reas H. D. Neurochemical responses of mice to ACTH and lysine vasopressin. Pharmacology, Biochemistry & Behavior 1976; 5: 139–145
   PubMed Web of Science ®Google Scholar
• Eberle A. N. The melanotropins. Karger, Basel 1988; 173–209
   Google Scholar
• Ehrensing R. H. Lithium and M.R.I.H. in tardive dyskinesia. Lancet 1974; 2: 1459–1460
   PubMed Web of Science ®Google Scholar
• Ferrari W., Gessa G. L., Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSH. Annals of the New York Academy of Science 1963; 104: 330–345
   PubMed Web of Science ®Google Scholar
• Fischer P. A., Schneider E., Jacobi P., Maxion H. Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrome. European Neurology 1974; 12: 360–368
   PubMed Web of Science ®Google Scholar
• Hartley R., Padwick D., Smith J. A. The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and chlopromazine. Journal of Pharmacology and Pharmacy 1972; 24(Suppl)100P–103P
   Google Scholar
• Hassan M. M., Bottoms S. F., Evans M. I., Dombrowski M. P., Mariona F. G., Mukherjee A. B. Fetal-alpha-melanocyte-stimulating hormone levels: No correlation with late fetal growth but increased with diabetes mellitus. American Journal of Obstetrics and Gynecology 1986; 154: 428–430
   PubMed Web of Science ®Google Scholar
• Hollt V., Haarmann I., Seizinger B. R., Herz A. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary. Endocrinology 1982; 110: 1885–1891
   PubMed Web of Science ®Google Scholar
• Honnebier W. J., Swaab D. F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. Journal of Obstetrics and Gynecology 1973; 80: 577–581
   Google Scholar
• Ito T., Yeh W. H., Nishiyama K. Secretory activity of the intraocular homo-transplanted pars intermedia of the frog, Rana nigromaculata. Neuroendocrinology 1986; 43: 689–695
   PubMed Web of Science ®Google Scholar
• Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of adrenocorticotropin(1–24) in rat brainstem. Science 1983; 218: 175–177
   Web of Science ®Google Scholar
• Jacquet Y. F. Dystonia'-like postural asymmetry after microinjection of ACTHN-terminal fragments but not after ACTH1–39 in rat brainstem suggests role of neuropeptide mutation in genetic movement disorder. Brain Research 1984; 294: 144–147
   PubMed Web of Science ®Google Scholar
• Jakob H., Beckman H. Prenatal development disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission 1986; 65: 303–326
   PubMed Web of Science ®Google Scholar
• Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. Journal of Clinical Psychopharmacology 1988; 8(suppl)52S–56S
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Kullander S., Borglin N. E., Dahlberg B., Dyster-Aas K., Krakau C. E. T., Ingvar D. H., Miller M. C., Bowers C. Y., Schally A. V. Extrapigmentary effects of melanocyte-stimulating hormone in amenorrheic women. Lancet 1968; 1: 1007–1010
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pinealectomy. Proceedings of the Society for Experimental Biology and Medicine 1967; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Schally A. V., Viosca S., Miller M. D. MSH activity in plasma and pituitaries of rats after various treatments. Endocrinology 1969; 84: 20–27
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Viosca S., Nair R. M. G., Schally A. V., Miller M. C. Interactions between pineal, hypothalamus and pituitary involving melatonin, MSH release-inhibiting factor and MSH. Endocrinology 1972; 91: 1323–1328
   PubMed Web of Science ®Google Scholar
• Klawans H. L., Barr A. Prevalence of spontaneous lingual-facial-buccal dyskinesias in the elderly. Neurology 1982; 32: 558–559
   PubMed Web of Science ®Google Scholar
• Klawans H. L., Goetz C. G., Perlik S. Tardive dyskinesia: review and update. American Journal of Psychiatry 1980; 137: 900–908
   PubMed Web of Science ®Google Scholar
• Klawans H. L., Tanner C. M., Barr A. The reversibility of “permanent” tardive dyskinesia. Clinical Neuropharmacology 1984; 7: 153–159
   PubMed Web of Science ®Google Scholar
• Leonard B. E. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain. Archives of International Pharmacodynamics & Therapy 1974; 207: 242–243
   PubMedGoogle Scholar
• Lindenmayer J. P., Gardner E., Goldberg E., Opler L. A., Kay S. R., Van Praag H. M., Weiner M., Zukin S. High-dose naloxone in tardive dyskinesia. Psychiatry Research 1988; 26: 19–28
   PubMed Web of Science ®Google Scholar
• Miller L. H., Kastin A. J., Sandman C. A., Fink M., Van Veen W. J. Polypeptide influence on attention, memory, and anxiety in man. Pharmacology Biochemistry & Behavior 1978; 2: 664–671
   Google Scholar
• Moriarty C. M., Moriarty G. C. Bioactive and immunoactive ACTH in the rat pituitary: influence of stress and adrenalectomy. Endocrinology 1975; 96: 1419–1425
   PubMed Web of Science ®Google Scholar
• Mukherjee S., Bilder R. M., Sackheim H. A. Tardive dyskinesia and glucose metabolism. Archives of General Psychiatry 1986; 43: 193
   Web of Science ®Google Scholar
• O'Donohue T. L., Dorsa D. M. The opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Jacobowitz D. M. Studies on alpha-melanotropin in the central nervous system. Polypeptide Hormones, R. F. Beers, E. G. Basset. Raven Press, New York 1980; 203–222
   Google Scholar
• Pique L., Jegou S., Bertagna X., Javoy-Agid F., Seurin D., Proeschel M. F., Girard F., Agid Y., Vaudry H., Luton J. P. Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients. Neuroscience Letters 1985; 54: 141–146
   PubMed Web of Science ®Google Scholar
• Rainero I., Kaye J. A., May C., Durso R., Katz D. I., Albert M. L., Wolfe N., Pinessi L., Friedland R. P., Rapoport S. I. Alpha-melanocyte stimulating hormone-like immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology 1988; 45: 1224–1227
   PubMedGoogle Scholar
• Richardson M. A., Craig T. J. The coexistence of Parkinsonism-like symptoms and tardive dyskinesia. American Journal of Psychiatry 1982; 139: 341–343
   PubMed Web of Science ®Google Scholar
• Rivier C., Vale W. Influence of the frequency of ovine-corticotropin releasing factor administration on adrenocorticotropin and corticosterone in the rat. Endocrinology 1983; 113: 1422–1426
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
   PubMed Web of Science ®Google Scholar
• Sandman C. A., Kastin A. J. Interaction of the alpha-MSH and MIF-I with amphetamine on open-field behavior of rats. Pharmacology, Biochemistry & Behavior 1978; 9: 759–762
   PubMed Web of Science ®Google Scholar
• Sandyk R., Snider S. R. Naloxone and tardive dyskinesia. Biological Psychiatry 1985; 20: 1335–1336
   PubMed Web of Science ®Google Scholar
• Sandyk R. Melanocyte-stimulating hormone (MSH) in the restless legs syndrome. International Journal of Neurosicence 1989; 46: 197–199
   PubMed Web of Science ®Google Scholar
• Sandyk R. Melanocyte-stimulating hormone in Tourette's syndrome. International Journal of Neuroscience 1989; 44: 161–164
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence and severity of neuroleptic-induced movement disorder in pinealectomized rats. International Journal of Neuroscience 1989; 48: 297–301
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P., Bamford C. R. The hypothalamus in Parkinson's disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
   PubMedGoogle Scholar
• Smith J. M., Baldessarini R. J. Changes in prevalence, severity and recovery in tardive dyskinesia with age. Archives of General Psychiatry 1979; 36: 585–590
   PubMed Web of Science ®Google Scholar
• Sorokin J. E., Giordani B., Mohs R. C., Losonczy M. F., Davidson M., Siever L. J., Ryan T. A., Davis K. L. Memory impairment in schizophrenic patients with tardive dyskinesia. Biological Psychiatry 1988; 23: 129–135
   PubMed Web of Science ®Google Scholar
• Torre E., Celis M. E., Chiocchio S. R. Alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): Influence of dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP). Peptides 1984; 5: 669–674
   PubMed Web of Science ®Google Scholar
• Ustegui R., Oliver C., Vaudry H., Lombardi G., Rozenberg I., Mourie A. M. Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary. Endocrinology 1976; 98: 189–196
   PubMed Web of Science ®Google Scholar
• Vecsei L., Bollok I., Telegdy G., Schally A. V. Comparative studies with beta-(Tyr)-9 melanotropin-(-18) and amphetamine on open-field behavior and striatal dopamine uptake and release. Pharmacological Research Communication 1984; 16: 689–697
   PubMedGoogle Scholar
• Versteeg D. H. G. ACTH/MSH-related neuropeptides as modulators of central neurotransmisison. Abstract First Joint Meeting of the Italian and Dutch Pharmacological Societies, FlorenceItaly, 1987; 56–58
   Google Scholar
• Weinberger D. R. Computed tomography (CT) findings in schizophrenia: Speculations on the meaning of it all. Journal of Psychiatric Research 1984; 18: 477–490
   PubMed Web of Science ®Google Scholar
• Wood P. L., Malthe-Sorenssen D., Cheney D. L., Costa E. Increase of hippocampal acetylcholine turnover rate and the stretching-yawning syndrome elicted by alpha-MSH and ACTH. Life Sciences 1978; 22: 673–678
   PubMed Web of Science ®Google Scholar
• Youssef H. A., Waddington J. L. Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder. Overrepresentation in patients with Tardive dyskinesia. Biological Psychiatry 1988; 23: 791–796
   PubMed Web of Science ®Google Scholar